GlucoTrack Average Inventory from 2010 to 2026
| GCTK Stock | USD 1.77 0.19 9.69% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 507.8 K | Current Value 582.5 K | Quarterly Volatility 380.9 K |
Check GlucoTrack financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GlucoTrack's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.5 K, Interest Expense of 650 K or Selling General Administrative of 5.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 84.45. GlucoTrack financial statements analysis is a perfect complement when working with GlucoTrack Valuation or Volatility modules.
GlucoTrack | Average Inventory | Build AI portfolio with GlucoTrack Stock |
Historical Average Inventory data for GlucoTrack serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether GlucoTrack represents a compelling investment opportunity.
Latest GlucoTrack's Average Inventory Growth Pattern
Below is the plot of the Average Inventory of GlucoTrack over the last few years. It is the average amount of inventory a company holds over a certain period, which is used to calculate inventory turnover and efficiency in managing stock levels. GlucoTrack's Average Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GlucoTrack's overall financial position and show how it may be relating to other accounts over time.
| Average Inventory | 10 Years Trend |
|
Average Inventory |
| Timeline |
GlucoTrack Average Inventory Regression Statistics
| Arithmetic Mean | 510,170 | |
| Geometric Mean | 295,917 | |
| Coefficient Of Variation | 74.66 | |
| Mean Deviation | 275,780 | |
| Median | 564,174 | |
| Standard Deviation | 380,886 | |
| Sample Variance | 145.1B | |
| Range | 1.1M | |
| R-Value | 0.39 | |
| Mean Square Error | 131.1B | |
| R-Squared | 0.15 | |
| Significance | 0.12 | |
| Slope | 29,483 | |
| Total Sum of Squares | 2.3T |
GlucoTrack Average Inventory History
About GlucoTrack Financial Statements
GlucoTrack investors utilize fundamental indicators, such as Average Inventory, to predict how GlucoTrack Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Average Inventory | 507.8 K | 582.5 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of GlucoTrack Correlation against competitors. For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. Market participants price GlucoTrack higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive GlucoTrack assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, GlucoTrack's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.